Results 191 to 200 of about 37,774 (258)

Repurposed Arylidene-hydrazinyl-1,3-thiazoles as Multitarget Anti-Alzheimer's Agents via Combined Computational and Experimental Studies. [PDF]

ACS Omega
Drozdowska D, Ratkiewicz A, Wróbel-Tałałaj A, Parzych C, El-Dershaby HA, Abd El-Razik HA, Soliman FSG, El-Wakil MH.   +7 more
europepmc   +1 more source

Cholinesterase inhibitors in the treatment of Alzheimer's disease [PDF]

, 2013
Camps Cardenal, Laura, Universitat Autònoma de Barcelona. Facultat de Biociències   +1 more
core  

Concomitant use of psychotropics and donepezil in Japanese patients with dementia: Pooled postmarketing surveillance data analysis

, 2016
Kasumi Daidoji, Yukinori Sakata, Kenta Sumitomo, Mika Ishii, Tetsumi Toyoda, Mika Kawaguchi   +5 more
openalex   +1 more source

Identification of stigmasterol derived AChE inhibitors for Alzheimer's disease using high throughput virtual screening and molecular dynamics simulations. [PDF]

Sci Rep
Rahman MO, Ahmed SS, Alqahtani AS, Rehman MT, Sultana N, Bouhrim M, Ali MA, Lee J.   +7 more
europepmc   +1 more source

An evaluation of Roluperidone as a promising repurposing candidate for Alzheimer's Disease: A Computational Investigation. [PDF]

PLoS One
Tanjin R, Al-Amin M, Etee JM, Siddika A, Siddiki A, Mahi SI, Toma SN, Akter N, Uddin MH, Bristy NA, Mowlee SI, Rafa EK, Hossen MF.   +12 more
europepmc   +1 more source

Introduction of Cistanche phelypaea fatty acids as a new natural neurotrophic supplement by evaluating its effects in normal and Alzheimer's diseased rats. [PDF]

Sci Rep
Aboubaker DH, Elsayed AAA, El-Gohary A, El-Garf IA, Ibrahim BMM.   +4 more
europepmc   +1 more source